BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 778556)

  • 1. Hepatorenal syndrome: a disease mediated by the intrarenal action of renin.
    Ziegler TW
    Med Hypotheses; 1976; 2(1):15-21. PubMed ID: 778556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function.
    Cade R; Wagemaker H; Vogel S; Mars D; Hood-Lewis D; Privette M; Peterson J; Schlein E; Hawkins R; Raulerson D
    Am J Med; 1987 Mar; 82(3):427-38. PubMed ID: 3548346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of the renin-angiotensin system on autoregulation of renal blood flow and intrarenal hemodynamics (author's transl)].
    Brech WJ
    Klin Wochenschr; 1976 Mar; 54(6):245-54. PubMed ID: 772295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Des-1-Asp-angiotensin II. Possible intrarenal role in homeostasis in the dog.
    Freeman RH; Davis JO; Lohmeier TE
    Circ Res; 1975 Jul; 37(1):30-4. PubMed ID: 1149185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-II acts centrally to alter renal sympathetic nerve activity and the intrarenal renin-angiotensin system.
    Weekley LB
    Cardiovasc Res; 1991 May; 25(5):353-63. PubMed ID: 1855240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal failure in advanced liver disease.
    Baldus WP
    Prog Liver Dis; 1972; 4():251-67. PubMed ID: 4347066
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of angiotensin II antagonist infusion on autoregulation of renal blood flow.
    Abe Y; Kishimoto T; Yamamoto K
    Am J Physiol; 1976 Oct; 231(4):1267-71. PubMed ID: 984212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of propranolol in a histologically appropriate model of postischemic acute renal failure.
    Solez K; D'Agostini RJ; Stawowy L; Freedman MT; Scott WW; Siegelman SS; Heptinstall RH
    Am J Pathol; 1977 Jul; 88(1):163-92. PubMed ID: 879269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatorenal syndrome. A review.
    Altman KA
    Am J Gastroenterol; 1968 May; 49(5):436-9. PubMed ID: 4297522
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation.
    Anderson RJ; Taher MS; Cronin RE; McDonald KM; Schrier RW
    Am J Physiol; 1975 Sep; 229(3):731-6. PubMed ID: 813531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between renin and intrarenal hemodynamics in hemorrhagic hypotension.
    Grandchamp A; Veyrat R; Rosset E; Scherrer JR; Truniger B
    J Clin Invest; 1971 May; 50(5):970-8. PubMed ID: 4324073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites.
    Wilkinson SP; Bernardi M; Smith IK; Jowett TP; Slater JD; Williams R
    Gastroenterology; 1977 Oct; 73(4 Pt 1):659-63. PubMed ID: 19338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intrarenal renin inhibition on renal hemodynamics and excretory function.
    Verburg KM; Kadam JR; Young GA; Rosenberg SH; Kleinert HD
    Am J Physiol; 1990 Jul; 259(1 Pt 2):R7-14. PubMed ID: 2197881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
    Ando M
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.
    Laragh JH; Sealey JE; Bühler FR; Vaughan ED; Brunner HR; Gavras H; Baer L
    Am J Med; 1975 Jan; 58(1):4-13. PubMed ID: 234677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrarenal role of renin-angiotensin system in the regulation of renal hemodynamics.
    Abe Y; Okahara T; Kishimoto T; Yamamoto K
    Jpn J Pharmacol; 1979 Jun; 29(3):325-33. PubMed ID: 395347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and action of prostaglandins in the kidney.
    Weber PC; Scherer B; Siess W; Held E; Schnermann J
    Klin Wochenschr; 1979 Oct; 57(19):1021-9. PubMed ID: 533977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.